Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. - Bauer,S.; Corless,C.L.; Heinrich,M.C.; Dirsch,O.; Antoch,G.; Kanja,J.; Seeber,S.; Schutte,J. (Cancer Chemother Pharmacol, 2003)